Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,881 | 655 | 94.6% |
| Education | $684.64 | 16 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,441 | 73 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $1,081 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $998.33 | 58 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $943.34 | 42 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $726.51 | 32 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $683.85 | 38 | $0 (2024) |
| Vifor Pharma, Inc. | $668.94 | 30 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $524.61 | 36 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $524.43 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $456.91 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,020 | 97 | Amgen Inc. ($491.46) |
| 2023 | $1,884 | 97 | Mallinckrodt Hospital Products Inc. ($347.01) |
| 2022 | $1,663 | 88 | Alexion Pharmaceuticals, Inc. ($232.03) |
| 2021 | $1,386 | 64 | Mallinckrodt Hospital Products Inc. ($295.68) |
| 2020 | $999.40 | 56 | Mallinckrodt Hospital Products Inc. ($173.36) |
| 2019 | $1,676 | 86 | Mallinckrodt Enterprises LLC ($355.13) |
| 2018 | $1,638 | 91 | Mallinckrodt LLC ($302.57) |
| 2017 | $1,299 | 92 | Mallinckrodt LLC ($285.64) |
All Payment Transactions
671 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $33.56 | General |
| 12/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Nephrology | ||||||
| 12/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: NEPHROLOGY | ||||||
| 11/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | Aranesp (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Nephrology | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEPHROLOGY | ||||||
| 10/16/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $26.75 | General |
| 10/13/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Nephrology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,211 | 2,626 | $693,045 | $263,078 |
| 2022 | 16 | 1,286 | 2,872 | $732,721 | $256,462 |
| 2021 | 12 | 1,225 | 2,988 | $712,940 | $280,452 |
| 2020 | 11 | 1,162 | 2,809 | $599,536 | $269,199 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 42 | 242 | $166,254 | $64,781 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 324 | 511 | $125,195 | $43,822 | 35.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 367 | $71,932 | $32,141 | 44.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 475 | $64,600 | $28,192 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 128 | 168 | $63,840 | $21,960 | 34.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 16 | 78 | $44,304 | $16,556 | 37.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 31 | 67 | $38,056 | $15,301 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 97 | $33,271 | $12,063 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $20,288 | $6,800 | 33.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 37 | 39 | $20,592 | $6,320 | 30.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 30 | 138 | $13,110 | $4,987 | 38.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 30 | 114 | $12,768 | $3,964 | 31.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 42 | 54 | $7,556 | $2,945 | 39.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 116 | 182 | $6,006 | $1,529 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,598 | $1,485 | 32.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 18 | 19 | $675.28 | $232.05 | 34.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 46 | 268 | $179,349 | $71,924 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 548 | $134,260 | $38,369 | 28.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 556 | $75,616 | $29,957 | 39.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 124 | 394 | $77,224 | $29,606 | 38.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 114 | $43,320 | $16,085 | 37.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 27 | 63 | $35,784 | $14,094 | 39.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 14 | 61 | $34,648 | $13,625 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 90 | 145 | $49,735 | $12,191 | 24.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 58 | 61 | $32,208 | $9,082 | 28.2% |
About Dr. Urath Suresh, MD
Dr. Urath Suresh, MD is a Nephrology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629061874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Urath Suresh, MD has received a total of $12,565 in payments from pharmaceutical and medical device companies, with $2,020 received in 2024. These payments were reported across 671 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,881).
As a Medicare-enrolled provider, Suresh has provided services to 4,884 Medicare beneficiaries, totaling 11,295 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Knoxville, TN
- Active Since 08/23/2005
- Last Updated 03/07/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1629061874
Products in Payments
- ACTHAR (Biological) $1,829
- Veltassa (Drug) $948.65
- KRYSTEXXA (Biological) $732.11
- LOKELMA (Drug) $571.72
- LUPKYNIS (Drug) $524.43
- Parsabiv (Drug) $520.77
- Kerendia (Drug) $456.91
- JYNARQUE (Drug) $444.77
- INJECTAFER (Drug) $379.40
- Velphoro (Drug) $367.02
- Rayaldee (Drug) $324.77
- FARXIGA (Drug) $322.03
- Parsabiv (Biological) $299.27
- ULTOMIRIS (Biological) $284.86
- Auryxia (Drug) $275.41
- SAMSCA (Drug) $239.08
- AURYXIA (Drug) $229.46
- RAYALDEE (Drug) $199.84
- TERLIVAZ (Drug) $194.90
- TARPEYO (Drug) $172.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Knoxville
Gerald Borrelli, M.d, M.D
Nephrology — Payments: $252,660
Denise Rivers, Do, DO
Nephrology — Payments: $8,727
Kaitlin Desrosiers, Fnp-C, FNP-C
Nephrology — Payments: $4,862
Jimmy Gentry, M.d, M.D
Nephrology — Payments: $2,486
Mrs. Kendra Hendon, M.d, M.D
Nephrology — Payments: $1,510
Asif Sultan, M.d, M.D
Nephrology — Payments: $1,234